<DOC>
	<DOCNO>NCT00368251</DOCNO>
	<brief_summary>The study compare efficacy safety Brivaracetam placebo patient Unverricht- Lundborg Disease ( ULD ) .</brief_summary>
	<brief_title>Brivaracetam add-on Treatment Unverricht-Lundborg Disease ( ULD ) Adolescents Adults</brief_title>
	<detailed_description />
	<mesh_term>Unverricht-Lundborg Syndrome</mesh_term>
	<criteria>Subjects diagnose UnverrichtLundborg disease ( ULD ) ascertain appropriate genetic test homozygous compound heterozygous mutation CSTB gene Subjects moderate severe myoclonus document Action Myoclonussum score â‰¥ 30 ( evaluation investigator ) Subjects currently treat clonazepam maximum recommend daily dose 20 mg individual optimal dose assess investigator Subjects currently treat valproate maximum recommend daily dose 60 mg/kg serum level 100 mcg/ml individual optimal dose specify investigator Male/female subject 16 year onwards . Subjects 18 year may include legally permit ethically accepted Subjects currently felbamate felbamate within less 18 month prior Visit 1 Subjects currently treat phenytoin phenytoin last month prior Visit 1 Subjects currently vigabatrine . Subjects vigabatrine visual field examination report available include standard static ( Humphrey Octopus ) cinetic perimetry ( Goldman ) Subject take drug possible central nervous system ( CNS ) effect Subjects take drug may significantly influence metabolism BRV ( CYP2C CYP3A potent inducers/inhibitors ) Known clinically significant acute chronic illness illness may impair reliable participation trial , necessitate use medication allow protocol represent safety risk Investigator 's opinion Subjects history severe adverse hematological reaction drug Impaired hepatic function : ALAT/SGPT , ASAT/SGOT , alkaline phosphatase , GGT value three time upper limit reference range History suicide attempt last 5 year Subject suicidal ideation within last year risk suicide attempt unless clear write confirmation psychiatrist approve UCB physician Ongoing psychiatric disorder mild control disorder</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Unverricht-Lundborg Disease</keyword>
	<keyword>Baltic Myoclonus</keyword>
	<keyword>Progressive Myoclonic Epilepsies</keyword>
	<keyword>Myoclonus</keyword>
	<keyword>Brivaracetam</keyword>
</DOC>